Kojin Pharma-B (02171) has granted 2.667 million stock options.

Zhitong Finance · Nov 18 20:51

Kangji Pharmaceuticals-B (02171) announced that on November 18, 2024, the company made purchases based on the terms of the initial public offering...

According to the news from the Wise Finance APP, Kangji Pharmaceuticals-B (02171) announced that on November 18, 2024, the company granted 2.667 million share purchase rights to 31 share purchase grantors under the terms of the initial public offering share purchase plan, but they must wait for the recipients to accept before they can take effect. The exercise price of the granted share purchase rights is HKD 7.26 per share.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

科济药业-B(02171)授出266.7万份购股权

Kojin Pharma-B (02171) has granted 2.667 million stock options.

Risk Disclaimer

Statement